MedTrace Logo

PVI Using Cryoablation Alone in Paroxysmal AF Patients Converted From Persistent AF With Dofetilide

NCT01877486 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2016-10-04

No results posted yet for this study

Summary

To determine the efficacy of cryoablation alone in patients with paroxysmal atrial fibrillation who have been pretreated with dofetilide and converted from persistent atrial fibrillation.

Conditions

  • Paroxysmal Atrial Fibrillation
  • Persistent Atrial Fibrillation

Interventions

PROCEDURE

Ablation

Pulmonary vein isolation following dofetilide

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • University of Rochester

    lead OTHER

Principal Investigators

  • Jonathan S Steinberg, MD · University of Rochester

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-06-30
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01877486 on ClinicalTrials.gov